Meeting
2015 ASCO Annual Meeting
Analysis of BRAF alterations and molecular profiling in glioblastoma and astrocytoma .
Authors
Nadia Faiq
UC San Diego Moores Cancer Center, San Diego, CA
Nadia Faiq , Juliann Chmielecki , Michael Goldberg , Phil Stephens , Razelle Kurzrock , Santosh Kesari , David Eric Piccioni
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Central Nervous System Tumors
Citation
J Clin Oncol 33, 2015 (suppl; abstr 2074)
DOI
10.1200/jco.2015.33.15_suppl.2074
Abstract #
2074
Poster Bd #
64
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
A powerful drug combination strategy targeting BRAF-mutant melanoma.
First Author: Luke Daniel Rothermel
Poster
2023 ASCO Annual Meeting
New ESMO scale for clinical actionability of molecular targets (ESCAT) for gliomas based on a multicentric real world data cohort using next-generation sequencing (NGS).
First Author: Oriol Mirallas
Poster
2017 ASCO Annual Meeting
Comprehensive assessment of ATRX mutation, protein expression, and alternative lengthening of telomeres (ALT) phenotype in grade II and III gliomas.
First Author: Aline P. Becker
Poster
2016 ASCO Annual Meeting
Influence of melanocortin-1 receptor (MC1R) polymorphisms on clinical outcomes of patients with metastatic melanoma harboring the BRAF mutation and treated with BRAF inhibitors.
First Author: Sabino Strippoli